scPharmaceuticals Inc [SCPH] stock is trading at $3.39, up 2.42%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The SCPH shares have gain 6.27% over the last week, with a monthly amount glided 0.89%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
scPharmaceuticals Inc [NASDAQ: SCPH] stock has seen the most recent analyst activity on September 07, 2023, when Craig Hallum initiated its Buy rating and assigned the stock a price target of $20. Previously, Cowen started tracking the stock with Outperform rating on December 01, 2022, and set its price target to $25. SVB Leerink upgraded its rating to a Outperform but stick to its price target of $11 on October 11, 2022. Maxim Group initiated its recommendation with a Buy and recommended $10 as its price target on August 02, 2022. SVB Leerink started tracking with a Mkt Perform rating for this stock on September 09, 2021, and assigned it a price target of $6. In a note dated October 15, 2019, H.C. Wainwright initiated an Buy rating and provided a target price of $13 on this stock.
scPharmaceuticals Inc [SCPH] stock has fluctuated between $3.08 and $6.71 over the past year. Currently, Wall Street analysts expect the stock to reach $13 within the next 12 months. scPharmaceuticals Inc [NASDAQ: SCPH] shares were valued at $3.39 at the most recent close of the market. An investor can expect a potential return of 283.48% based on the average SCPH price forecast.
Analyzing the SCPH fundamentals
scPharmaceuticals Inc [NASDAQ:SCPH] reported sales of 30.28M for the trailing twelve months, which represents a growth of 164.12%. Gross Profit Margin for this corporation currently stands at 0.7% with Operating Profit Margin at -2.1%, Pretax Profit Margin comes in at -2.65%, and Net Profit Margin reading is -2.65%. To continue investigating profitability, this company’s Return on Assets is posted at -0.64, Equity is -3.15 and Total Capital is -0.58. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of1.67.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 3.27 points at the first support level, and at 3.15 for the second support level. However, for the 1st resistance point, the stock is sitting at 3.48, and for the 2nd resistance point, it is at 3.57.
Ratios To Look Out For
For context, scPharmaceuticals Inc’s Current Ratio is 8.08. Further, the Quick Ratio stands at 6.89, while the Cash Ratio is 5.99. Considering the valuation of this stock, the price to sales ratio is 5.74, the price to book ratio is 5.52.
Transactions by insiders
Recent insider trading involved ORBIMED ADVISORS LLC, 10% Owner, that happened on Aug 13 ’24 when 0.5 million shares were purchased.
